Article Dans Une Revue Bioanalysis Année : 2018

Development and validation of an ELISA to study panitumumab pharmacokinetics

Résumé

Panitumumab is a monoclonal antibody directed against EGFR that is approved for the treatment of metastatic colorectal cancer. To investigate its pharmacokinetics and concentration-response relationship, a validated assay is required.

Fichier non déposé

Dates et versions

hal-02372863 , version 1 (20-11-2019)

Identifiants

Citer

Celine Desvignes, Christophe Passot, David Ternant, Morgane Caulet, Caroline Guérineau, et al.. Development and validation of an ELISA to study panitumumab pharmacokinetics. Bioanalysis, 2018, 10 (4), pp.205-214. ⟨10.4155/bio-2016-0292⟩. ⟨hal-02372863⟩

Collections

89 Consultations
0 Téléchargements

Altmetric

Partager

  • More